FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 342:989-997 April 6, 2000 Number 14 Next

	Full Text PDF Editorial by Haffner, S. M. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background Acute myocardial infarction in patients with diabetes is associated with high mortality. We studied whether previous revascularization by coronary-artery bypass grafting (CABG), as compared with percutaneous transluminal coronary angioplasty (PTCA), influences the prognosis in such patients.

Methods We classified all patients eligible for the Bypass Angioplasty Revascularization Investigation who underwent coronary revascularization within three months after entry into the study according to whether they had diabetes and whether they had undergone CABG, either initially or after PTCA. The protective effect of CABG with regard to mortality in the presence and in the absence of subsequent spontaneous Q-wave myocardial infarction was estimated with the use of Cox regression models.

Results Among the 641 patients with diabetes and the 2962 without diabetes, the cumulative five-year rates of death were 20 percent and 8 percent, respectively (P<0.001), and the five-year rates of spontaneous Q-wave myocardial infarction were 8 percent and 4 percent (P<0.001). CABG greatly reduced the risk of death after spontaneous Q-wave myocardial infarction in the patients with diabetes (relative risk, 0.09; 95 percent confidence interval, 0.03 to 0.29). Among patients with diabetes who had undergone CABG but did not have spontaneous Q-wave myocardial infarction, the corresponding relative risk of death was 0.65 (95 percent confidence interval, 0.45 to 0.94). Among the patients without diabetes, no protective effect of CABG was evident.

Conclusions Among patients with diabetes, previous coronary bypass surgery, as compared with coronary angioplasty, has a highly favorable influence on prognosis after acute myocardial infarction and a smaller beneficial effect among patients who do not have infarction. These findings should influence the type of coronary revascularization procedure selected for patients with diabetes who have multivessel coronary artery disease.

Source Information

From the Bypass Angioplasty Revascularization Investigation Coordinating Center, University of Pittsburgh, Pittsburgh (K.M.D., M.S.L., M.M.B., R.M.H., R.H.); the National Institutes of Health, Bethesda, Md. (G.S.); the Mayo Clinic Foundation, Rochester, Minn. (R.L.F.); and St. Louis University Health Sciences Center, St. Louis (B.R.C.).

Address reprint requests to Dr. Detre at the BARI Coordinating Center, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto St., 127 Parran Hall, Pittsburgh, PA 15261, or at detre{at}edc.gsph.pitt.edu.

Full Text of this Article

This article has been cited by other articles:

• Brown, M. L., Sundt, T. M. III, Gersh, B. J. (2008). Indications for Revascularization. Card Surg Adult 3: 551-572 [Full Text]  
• Holmes, D. R. Jr, Kim, L. J., Brooks, M. M., Kip, K. E., Schaff, H. V., Detre, K. M., Frye, R. L., Bypass Angioplasty Revascularization Investigation, (2007). The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation. J. Thorac. Cardiovasc. Surg. 134: 38-46 [Abstract] [Full Text]  
• Berry, C., Tardif, J.-C., Bourassa, M. G. (2007). Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization. J Am Coll Cardiol 49: 643-656 [Abstract] [Full Text]  
• Barner, H. B. (2006). Status of percutaneous coronary intervention and coronary artery bypass.. Eur. J. Cardiothorac. Surg. 30: 419-424 [Abstract] [Full Text]  
• Lauruschkat, A. H., Arnrich, B., Albert, A. A., Walter, J. A., Amann, B., Rosendahl, U. P., Alexander, T., Ennker, J. (2005). Prevalence and Risks of Undiagnosed Diabetes Mellitus in Patients Undergoing Coronary Artery Bypass Grafting. Circulation 112: 2397-2402 [Abstract] [Full Text]  
• King, S. B. III, Dangas, G., Moses, J. W., King, S. B. III, Dangas, G., Moses, J. W. (2005). Surgery Is Preferred for the Diabetic With Multivessel Disease. Circulation 112: 1500-1515 [Full Text]  
• Flaherty, J. D., Davidson, C. J. (2005). Diabetes and Coronary Revascularization. JAMA 293: 1501-1508 [Abstract] [Full Text]  
• Jarvinen, O., Julkunen, J., Saarinen, T., Laurikka, J., Tarkka, M. R. (2005). Effect of Diabetes on Outcome and Changes in Quality of Life After Coronary Artery Bypass Grafting. Ann. Thorac. Surg. 79: 819-824 [Abstract] [Full Text]  
• Stevens, L.M., Carrier, M., Perrault, L.P., Hebert, Y., Cartier, R., Bouchard, D., Fortier, A., Pellerin, M. (2005). Influence of diabetes and bilateral internal thoracic artery grafts on long-term outcome for multivessel coronary artery bypass grafting. Eur. J. Cardiothorac. Surg. 27: 281-288 [Abstract] [Full Text]  
• Rana, B S, Lim, P O, Naas, A A O, Ogston, S A, Newton, R W, Jung, R T, Morris, A D, Struthers, A D (2005). QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests. Heart 91: 44-50 [Abstract] [Full Text]  
• Brener, S. J., Lytle, B. W., Casserly, I. P., Schneider, J. P., Topol, E. J., Lauer, M. S. (2004). Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features. Circulation 109: 2290-2295 [Abstract] [Full Text]  
• Fox, C. S., Sullivan, L., D'Agostino, R. B. Sr, Wilson, P. W.F. (2004). The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality: The Framingham Heart Study. Diabetes Care 27: 704-708 [Abstract] [Full Text]  
• Casey, C, Faxon, D. P (2004). Multi-vessel coronary disease and percutaneous coronary intervention. Heart 90: 341-346 [Full Text]  
• Holmes, D. R. Jr, Firth, B. G., Wood, D. L. (2004). Paradigm shifts in cardiovascular medicine. J Am Coll Cardiol 43: 507-512 [Abstract] [Full Text]  
• Corpus, R. A., George, P. B., House, J. A., Dixon, S. R., Ajluni, S. C., Devlin, W. H., Timmis, G. C., Balasubramaniam, M., O'Neill, W. W. (2004). Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43: 8-14 [Abstract] [Full Text]  
• Hurst, R. T., Lee, R. W. (2003). Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management. ANN INTERN MED 139: 824-834 [Abstract] [Full Text]  
• Rihal, C. S., Raco, D. L., Gersh, B. J., Yusuf, S. (2003). Indications for Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention in Chronic Stable Angina: Review of the Evidence and Methodological Considerations. Circulation 108: 2439-2445 [Full Text]  
• Graham, M. M., Ghali, W. A., Faris, P. D., Galbraith, P. D., Norris, C. M., Knudtson, M. L. (2003). Sex Differences in the Prognostic Importance of Diabetes in Patients With Ischemic Heart Disease Undergoing Coronary Angiography. Diabetes Care 26: 3142-3147 [Abstract] [Full Text]  
• Endo, M., Tomizawa, Y., Nishida, H. (2003). Bilateral Versus Unilateral Internal Mammary Revascularization in Patients With Diabetes. Circulation 108: 1343-1349 [Abstract] [Full Text]  
• Mak, K.-H., Faxon, D. P. (2003). Clinical studies on coronary revascularization in patients with type 2 diabetes. Eur Heart J 24: 1087-1103 [Abstract] [Full Text]  
• Werner, G. S., Richartz, B. M., Heinke, S., Ferrari, M., Figulla, H. R. (2003). Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur Heart J 24: 1134-1142 [Abstract] [Full Text]  
• Niefeld, M. R., Braunstein, J. B., Wu, A. W., Saudek, C. D., Weller, W. E., Anderson, G. F. (2003). Preventable Hospitalization Among Elderly Medicare Beneficiaries With Type 2 Diabetes. Diabetes Care 26: 1344-1349 [Abstract] [Full Text]  
• Charlson, M. E., Isom, O. W. (2003). Care after Coronary-Artery Bypass Surgery. NEJM 348: 1456-1463 [Full Text]  
• Sobel, B. E., Frye, R., Detre, K. M. (2003). Burgeoning Dilemmas in the Management of Diabetes and Cardiovascular Disease: Rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Circulation 107: 636-642 [Abstract] [Full Text]  
• Sundt, T. M. III, Gersh, B. J., Smith, H. C. (2003). Indications for Coronary Revascularization. Card Surg Adult 2: 541-559 [Full Text]  
• Laakso, M., Kuusisto, J. (2003). Diabetology for cardiologists. Eur Heart J Suppl 5: B5-B13 [Abstract]  
• Naik, M J, Abu-Omar, Y, Alvi, A, Wright, N, Henderson, A, Channon, K, Forfar, J C, Taggart, D P (2003). Total arterial revascularisation as a primary strategy for coronary artery bypass grafting. Postgrad. Med. J. 79: 43-48 [Abstract] [Full Text]  
• Schwartz, L., Kip, K. E., Frye, R. L., Alderman, E. L., Schaff, H. V., Detre, K. M. (2002). Coronary Bypass Graft Patency in Patients With Diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 106: 2652-2658 [Abstract] [Full Text]  
• Sedlis, S. P., Morrison, D. A., Lorin, J. D., Esposito, R., Sethi, G., Sacks, J., Henderson, W., Grover, F., Ramanathan, K. B., Weiman, D., Saucedo, J., Antakli, T., Paramesh, V., Pett, S., Vernon, S., Birjiniuk, V., Welt, F., Krucoff, M., Wolfe, W., Lucke, J. C., Mediratta, S., Booth, D., Murphy, E., Ward, H., Miller, L., Kiesz, S., Barbiere, C., Lewis, D., Investigators of the Department of Veterans Affair, (2002). Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol 40: 1555-1566 [Abstract] [Full Text]  
• Popma, J. J., Kuntz, R. E., Baim, D. S. (2002). A Decade of Improvement in the Clinical Outcomes of Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease. Circulation 106: 1592-1594 [Full Text]  
• Szabo, Z., Hakanson, E., Svedjeholm, R. (2002). Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann. Thorac. Surg. 74: 712-719 [Abstract] [Full Text]  
• Schinkel, A. F.L., Elhendy, A., van Domburg, R. T., Bax, J. J., Vourvouri, E. C., Sozzi, F. B., Valkema, R., Roelandt, J. R.T.C., Poldermans, D. (2002). Prognostic Value of Dobutamine-Atropine Stress Myocardial Perfusion Imaging in Patients With Diabetes. Diabetes Care 25: 1637-1643 [Abstract] [Full Text]  
• Beckman, J. A., Creager, M. A., Libby, P. (2002). Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management. JAMA 287: 2570-2581 [Abstract] [Full Text]  
• Detre, K. M., Holubkov, R. (2002). Coronary Revascularization on Balance: Robert L. Frye Lecture. Mayo Clin Proc. 77: 72-82 [Abstract]  
• Giri, S., Shaw, L. J., Murthy, D. R., Travin, M. I., Miller, D. D., Hachamovitch, R., Borges-Neto, S., Berman, D. S., Waters, D. D., Heller, G. V. (2002). Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease. Circulation 105: 32-40 [Abstract] [Full Text]  
• Mukamal, K. J., Nesto, R. W., Cohen, M. C., Muller, J. E., Maclure, M., Sherwood, J. B., Mittleman, M. A. (2001). Impact of Diabetes on Long-Term Survival After Acute Myocardial Infarction: Comparability of risk with prior myocardial infarction. Diabetes Care 24: 1422-1427 [Abstract] [Full Text]  
• Modest, G. A., Ray, K. K., Sheridan, P. J., Chan, K. H., Barr, D. A., Khakoo, A. Y., Rastegar, D. A., Hemingway, H., Crook, A. M., Timmis, A. D. (2001). Underuse of Coronary Revascularization Procedures. NEJM 345: 294-296 [Full Text]  
• King, S. B. III (2001). Coronary artery bypass graft or percutaneous coronary interventions in patients with diabetes: another nail in the coffin or "too close to call?". J Am Coll Cardiol 37: 1016-1018 [Full Text]  
• Sobel, B. E. (2001). Acceleration of Restenosis by Diabetes : Pathogenetic Implications. Circulation 103: 1185-1187 [Full Text]  
• Bardsley, J. K., Passaro, M. (2001). The Alphabet Soup of Diabetes Research Studies. Diabetes Spectr. 14: 44-48 [Abstract] [Full Text]  
• (2001). CABG Beats Angioplasty for Diabetics. Journal Watch Cardiology 2001: 2-2 [Full Text]  
• Wong, C.-K, White, H.D (2000). Dithering over the treatment of diabetics with acute myocardial infarction. Eur Heart J 21: 1907-1909  
• (2000). CABG Better Than Angioplasty for Diabetics. Journal Watch Cardiology 2000: 4-4 [Full Text]  
• Haffner, S. M. (2000). Coronary Heart Disease in Patients with Diabetes. NEJM 342: 1040-1042 [Full Text]